Top compounds associated with response to SMYD1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.036 0.3
mRNA TL-2-105 GDSC1000 pan-cancer AAC -0.036 0.3
mRNA CGP-082996 GDSC1000 pan-cancer AAC 0.057 0.3
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.3
mRNA paclitaxel UHNBreast pan-cancer AAC 0.34 0.3
mRNA PF-562271 GDSC1000 pan-cancer AAC -0.036 0.3
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.79 0.3
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.038 0.3
Download CSV